Chromogranin-A II
Device
Brahms GmbH
Total Payments
$20,100
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $20,100 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $20,100 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Chromogranin A as Surveillance biomarker in Patients with cARcinoids - the CASPAR study | Brahms GmbH | $20,100 | 0 |
Top Doctors Receiving Payments for Chromogranin-A II
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Houston, TX | $20,100 | 1 |
Ad
Manufacturing Companies
- Brahms GmbH $20,100
Product Information
- Type Device
- Total Payments $20,100
- Total Doctors 0
- Transactions 1
About Chromogranin-A II
Chromogranin-A II is a device associated with $20,100 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Brahms GmbH.
Payment data is available from 2018 to 2018. In 2018, $20,100 was paid across 1 transactions to 0 doctors.
The most common payment nature for Chromogranin-A II is "Unspecified" ($20,100, 100.0% of total).
Chromogranin-A II is associated with 1 research study, including "Chromogranin A as Surveillance biomarker in Patients with cARcinoids - the CASPAR study" ($20,100).